State Street Corp Aeglea Bio Therapeutics, Inc. Transaction History

State Street Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.11 - $0.46 $2,189 - $9,154	-19,900 Reduced 9.26%	195,089 $87,000
Q4 2022 Feb 14, 2023	BUY	$0.35 - $1.54 $19,600 - $86,240	56,000 Added 35.22%	214,989 $96,000
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $314,029 - $1.67 Million	-628,059 Reduced 79.8%	158,989 $80,000
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $54,243 - $138,363	29,007 Added 3.83%	787,048 $1.81 Million
Q4 2021 Feb 14, 2022	SELL	$3.5 - $8.42 $31,150 - $74,938	-8,900 Reduced 1.16%	758,041 $3.6 Million
Q3 2021 Nov 15, 2021	BUY	$6.03 - $7.95 $56,929 - $75,055	9,441 Added 1.25%	766,941 $6.1 Million
Q2 2021 Aug 16, 2021	BUY	$6.32 - $8.38 $246,638 - $327,029	39,025 Added 5.43%	757,500 $5.27 Million
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $59,886 - $75,921	-8,859 Reduced 1.22%	718,475 $5.69 Million
Q4 2020 Feb 16, 2021	BUY	$7.02 - $9.83 $494,790 - $692,847	70,483 Added 10.73%	727,334 $5.72 Million
Q3 2020 Nov 10, 2020	BUY	$6.51 - $9.33 $26,352 - $37,767	4,048 Added 0.62%	656,851 $4.66 Million
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $726,231 - $2 Million	181,105 Added 38.39%	652,803 $6.04 Million
Q1 2020 May 11, 2020	BUY	$3.51 - $8.48 $1.66 Million - $4 Million	471,698 New	471,698 $2.2 Million

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.